268 related articles for article (PubMed ID: 17449453)
1. In vitro reactivation potency of acetylcholinesterase reactivators--K074 and K075--to reactivate tabun-inhibited human brain cholinesterases.
Kuca K; Cabal J; Jun D; Musilek K
Neurotox Res; 2007 Feb; 11(2):101-6. PubMed ID: 17449453
[TBL] [Abstract][Full Text] [Related]
2. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
Kassa J; Jun D; Kuca K
J Enzyme Inhib Med Chem; 2007 Jun; 22(3):297-300. PubMed ID: 17674811
[TBL] [Abstract][Full Text] [Related]
3. In vitro reactivation of acetylcholinesterase using the oxime K027.
Kuca K; Kassa J
Vet Hum Toxicol; 2004 Feb; 46(1):15-8. PubMed ID: 14748409
[TBL] [Abstract][Full Text] [Related]
4. Potency of novel oximes to reactivate sarin inhibited human cholinesterases.
Jun D; Kuca K; Picha J; Koleckar V; Marek J
Drug Chem Toxicol; 2008; 31(1):1-9. PubMed ID: 18161504
[TBL] [Abstract][Full Text] [Related]
5. In vitro reactivation of tabun-inhibited acetylcholinesterase using new oximes--K027, K005, K033 and K048.
Kuca K; Cabal J
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S59-61. PubMed ID: 15141981
[TBL] [Abstract][Full Text] [Related]
6. Currently used cholinesterase reactivators against nerve agent intoxication: comparison of their effectivity in vitro.
Kuca K; Jun D; Bajgar J
Drug Chem Toxicol; 2007; 30(1):31-40. PubMed ID: 17364862
[TBL] [Abstract][Full Text] [Related]
7. Effective bisquaternary reactivators of tabun-inhibited AChE.
Kuca K; Cabal J; Musilek K; Jun D; Bajgar J
J Appl Toxicol; 2005; 25(6):491-5. PubMed ID: 16092078
[TBL] [Abstract][Full Text] [Related]
8. Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.
Musilek K; Holas O; Kuca K; Jun D; Dohnal V; Opletalova V; Dolezal M
Bioorg Med Chem Lett; 2007 Jun; 17(11):3172-6. PubMed ID: 17383875
[TBL] [Abstract][Full Text] [Related]
9. In vitro reactivating effects of standard and newly developed oximes on malaoxon-inhibited mouse brain acetylcholinesterase.
dos Santos AA; dos Santos DB; Dafre AL; de Bem AF; Souza DO; da Rocha JB; Kuca K; Farina M
Basic Clin Pharmacol Toxicol; 2010 Sep; 107(3):768-73. PubMed ID: 20406208
[TBL] [Abstract][Full Text] [Related]
10. Potency of new structurally different oximes to reactivate cyclosarin-inhibited human brain acetylcholinesterases.
Kuca K; Cabal J; Jun D; Bajgar J; Hrabinova M
J Enzyme Inhib Med Chem; 2006 Dec; 21(6):663-6. PubMed ID: 17252938
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J
Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
[TBL] [Abstract][Full Text] [Related]
12. Reactivation of sarin-inhibited pig brain acetylcholinesterase using oxime antidotes.
Kuca K; Jun D
J Med Toxicol; 2006 Dec; 2(4):141-6. PubMed ID: 18072133
[TBL] [Abstract][Full Text] [Related]
13. Effects of K074 and pralidoxime on antioxidant and acetylcholinesterase response in malathion-poisoned mice.
dos Santos AA; dos Santos DB; Ribeiro RP; Colle D; Peres KC; Hermes J; Barbosa AM; Dafré AL; de Bem AF; Kuca K; Farina M
Neurotoxicology; 2011 Dec; 32(6):888-95. PubMed ID: 21723318
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
Acta Medica (Hradec Kralove); 2005; 48(2):81-6. PubMed ID: 16259317
[TBL] [Abstract][Full Text] [Related]
15. Syntheses and in vitro evaluations of uncharged reactivators for human acetylcholinesterase inhibited by organophosphorus nerve agents.
Renou J; Mercey G; Verdelet T; Păunescu E; Gillon E; Arboléas M; Loiodice M; Kliachyna M; Baati R; Nachon F; Jean L; Renard PY
Chem Biol Interact; 2013 Mar; 203(1):81-4. PubMed ID: 23111374
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the ability of a new bispyridinium oxime--1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
Kuca K; Kassa J
J Enzyme Inhib Med Chem; 2003 Dec; 18(6):529-35. PubMed ID: 15008517
[TBL] [Abstract][Full Text] [Related]
17. In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase.
Kuca K; Cabal J; Kassa J; Jun D; Hrabinova M
J Toxicol Environ Health A; 2006 Aug; 69(15):1431-40. PubMed ID: 16766478
[TBL] [Abstract][Full Text] [Related]
18. In vitro reactivation of acetylcholinesterase inhibited by cyclosarin using bisquaternary pyridinium aldoximes K005, K033, K027 AND K048.
Kuca K; Sevelová-Bartosová L; Krejcová-Kunesová G
Acta Medica (Hradec Kralove); 2004; 47(2):107-9. PubMed ID: 15446359
[TBL] [Abstract][Full Text] [Related]
19. In vitro reactivation of sarin inhibited electric eel acetylcholinesterase by bis-pyridinium oximes bearing methoxy ether linkages.
Acharya J; Gupta AK; Mazumder A; Dubey DK
Toxicol In Vitro; 2008 Mar; 22(2):525-30. PubMed ID: 18061396
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice.
Kassa J; Humlicek V
Drug Chem Toxicol; 2008; 31(1):127-35. PubMed ID: 18161512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]